Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.

B Renouf,Émilie Hollville,A Pujals,Cécile Tétaud,Julie Garibal,Joëlle Wiels

Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.

2009

B Renouf
Émilie Hollville
A Pujals
Cécile Tétaud
Julie Garibal
Joëlle Wiels

Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein–Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells

Keywords:

Herpesviridae
Lymphoma
Virus
Cancer research
Hematology
Gammaherpesvirinae
Epstein–Barr virus
Virology
Apoptosis
Biology
Burkitt's lymphoma
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations